| Business Name: |
Spellman Christopher MD |
| Contact Person: |
Christopher Spellman |
| Address: |
477 North El Camino Real # C202, Encinitas, California 92024 |
| Phone Number: |
(760) 631-3500 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Rosenberg Jay MD - Encinitas, CA 92024
Breisch Stuart T MD - Encinitas, CA 92024
Backman John R MD - Encinitas, CA 92024
Patel Nayna MD - Encinitas, CA 92024
Smith Damon E MD - Encinitas, CA 92024
Buddin Deidre MD - Encinitas, CA 92024
Vogel Curt MD - Encinitas, CA 92024
Wood Christine MD - Encinitas, CA 92024
Farsad Ramin H MD - Encinitas, CA 92024
Tova Yonina MD - Encinitas, CA 92024
Fierer Adam S MD - Encinitas, CA 92024
Eastman Sarita D MD - Encinitas, CA 92024
Mansy Gina J MD - Encinitas, CA 92024
Kadry A E MD - Encinitas, CA 92024
Naitoh John MD - Encinitas, CA 92024
Erwin Kathleen MD - Encinitas, CA 92024
O'Connell Tara A MD - Encinitas, CA 92024
Korabathina Kalyani MD - Encinitas, CA 92024
Leonard William MD - Encinitas, CA 92024
Schechter Mark S MD - Encinitas, CA 92024
|
The company Spellman Christopher MD provides B2C services in the form of Doctors from its single location in California.
1 to 4 employees work for Spellman Christopher MD, and the business now earns $500.000 to $999.999 per annum.
Spellman Christopher MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Spellman Christopher MD, please call Christopher Spellman with the phone number (760) 631-3500 or visit its single location at 477 North El Camino Real # C202 in Encinitas, California 92024.
The location of the single location can also be found using the coordinates 33.05729,-117.26249.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.